(2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide

C220H256N40O14 — CID 167664064

IUPAC(2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide
SMILESCC(=O)N1CCN(c2ccc(NC(=O)[C@@H](NCCc3ccc(C)cc3)c3ccccc3)nc2)CC1.CC(=O)N1CCN(c2ccc(NC(=O)[C@H](NCCc3ccc(C)cc3)c3ccccc3)nc2)CC1.COc1cccc([C@@H](NCCc2ccc(C)cc2)C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c1.COc1cccc([C@H](NCCc2ccc(C)cc2)C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCC(=O)N(C)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCN(C)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCC(=O)N(C)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCN(C)CC3)cn2)c2ccccc2)cc1
InChIInChI=1S/4C28H33N5O2.2C27H29N5O2.2C27H33N5O/c2*1-21-8-10-22(11-9-21)14-16-29-27(23-6-4-3-5-7-23)28(35)31-25-13-12-24(20-30-25)33-17-15-26(34)32(2)18-19-33;2*1-21-8-10-23(11-9-21)14-15-29-27(24-6-4-3-5-7-24)28(35)31-26-13-12-25(20-30-26)33-18-16-32(17-19-33)22(2)34;2*1-19-7-9-20(10-8-19)13-14-28-26(21-5-4-6-24(15-21)34-3)27(33)31-25-12-11-22(16-29-25)23-17-30-32(2)18-23;2*1-21-8-10-22(11-9-21)14-15-28-26(23-6-4-3-5-7-23)27(33)30-25-13-12-24(20-29-25)32-18-16-31(2)17-19-32/h4*3-13,20,27,29H,14-19H2,1-2H3,(H,30,31,35);2*4-12,15-18,26,28H,13-14H2,1-3H3,(H,29,31,33);2*3-13,20,26,28H,14-19H2,1-2H3,(H,29,30,33)/t4*27-;4*26-/m10101010/s1
InChIKeySJKTZVZYROLZTK-YLOBAREHSA-N
MW3684.73 g/mol
LogP30.21
Rot. Bonds66

About (2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide

(2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide (PubChem CID 167664064) has the molecular formula C220H256N40O14 and a molecular weight of 3684.73 g/mol. Its IUPAC name is (2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide.

Molecular Properties

Compound Name(2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide
PubChem CID167664064
Molecular FormulaC220H256N40O14
Molecular Weight3684.73 g/mol
Exact Mass3682.05
IUPAC Name(2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide
SMILESCC(=O)N1CCN(c2ccc(NC(=O)[C@@H](NCCc3ccc(C)cc3)c3ccccc3)nc2)CC1.CC(=O)N1CCN(c2ccc(NC(=O)[C@H](NCCc3ccc(C)cc3)c3ccccc3)nc2)CC1.COc1cccc([C@@H](NCCc2ccc(C)cc2)C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c1.COc1cccc([C@H](NCCc2ccc(C)cc2)C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCC(=O)N(C)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCN(C)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCC(=O)N(C)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCN(C)CC3)cn2)c2ccccc2)cc1
InChIInChI=1S/4C28H33N5O2.2C27H29N5O2.2C27H33N5O/c2*1-21-8-10-22(11-9-21)14-16-29-27(23-6-4-3-5-7-23)28(35)31-25-13-12-24(20-30-25)33-17-15-26(34)32(2)18-19-33;2*1-21-8-10-23(11-9-21)14-15-29-27(24-6-4-3-5-7-24)28(35)31-26-13-12-25(20-30-26)33-18-16-32(17-19-33)22(2)34;2*1-19-7-9-20(10-8-19)13-14-28-26(21-5-4-6-24(15-21)34-3)27(33)31-25-12-11-22(16-29-25)23-17-30-32(2)18-23;2*1-21-8-10-22(11-9-21)14-15-28-26(23-6-4-3-5-7-23)27(33)30-25-13-12-24(20-29-25)32-18-16-31(2)17-19-32/h4*3-13,20,27,29H,14-19H2,1-2H3,(H,30,31,35);2*4-12,15-18,26,28H,13-14H2,1-3H3,(H,29,31,33);2*3-13,20,26,28H,14-19H2,1-2H3,(H,29,30,33)/t4*27-;4*26-/m10101010/s1
InChIKeySJKTZVZYROLZTK-YLOBAREHSA-N
XLogP30.21
TPSA593.42 Ų
H-Bond Donors16
H-Bond Acceptors42
Rotatable Bonds66
Heavy Atoms274
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003684.73
LogP ≤ 530.21
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1042

Analyze (2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[(3R,6S)-6-(2,3-difluorophenyl)-1-(2-methoxyethyl)-2-oxoazepan-3-yl]-4-(2-oxo-1,4-dihydropyrido[2,3-d]pyrimidin-3-yl)piperidine-1-carboxamide;N-[(3R,6S)-6-(2,3-difluorophenyl)-1-(2-methoxyethyl)-2-oxoazepan-3-yl]-4-(2-oxo-1,4-dihydropyrido[3,4-d]pyrimidin-3-yl)piperidine-1-carboxamide;N-[(3R,6S)-6-(2,3-difluorophenyl)-1-(2-methoxyethyl)-2-oxoazepan-3-yl]-4-(2-oxo-1,4-dihydropyrido[4,3-d]pyrimidin-3-yl)piperidine-1-carboxamide;N-[(3R,6S)-6-(2,3-difluorophenyl)-1-(2-methoxyethyl)-2-oxoazepan-3-yl]-4-(6-oxo-7H-imidazo[4,5-c]pyridazin-5-yl)piperidine-1-carboxamide;N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(5-methoxy-2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
CID 158971274
(2S)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[2-methoxy-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[2-(1-methylpyrazol-4-yl)pyrimidin-5-yl]-2-phenylacetamide
CID 158219284
3,3-dimethylbutan-2-ylbenzene;2,2-dimethyl-N-[(1-methylimidazol-4-yl)methyl]propanamide;2,2-dimethyl-N-[2-(4-methylphenyl)ethyl]propanamide;2,2-dimethyl-N-[(1-methylpiperidin-4-yl)methyl]propanamide;2,2-dimethyl-N-[(1-methylpyrazol-3-yl)methyl]propanamide;2,2-dimethyl-N-(1-phenylethyl)propanamide;bis(2,2-dimethyl-N-(2-phenylethyl)propanamide);2,2-dimethyl-N-phenylpropanamide;2,2-dimethyl-N-(2-pyridin-2-ylethyl)propanamide;2,2-dimethyl-N-(2-pyridin-4-ylethyl)propanamide;2,2-dimethyl-1-[4-(pyridin-3-ylmethyl)piperazin-1-yl]propan-1-one;2,2-dimethyl-N-(pyridin-3-ylmethyl)propanamide;N-[2-(4-ethylphenyl)ethyl]-2,2-dimethylpropanamide;methane;N-[2-(3-methoxyphenyl)ethyl]-2,2-dimethylpropanamide;methyl 3-(2,2-dimethylpropanoylamino)benzoate
CID 158236709
(2S)-2-(4-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-(4-methylpyrazol-1-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-(4-methylpyrazol-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-(4-methylpyrazol-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-(4-methylpyrazol-1-yl)-2-pyridinyl]-2-phenylacetamide
CID 158323717
(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;bis((2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide);bis((2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide);bis(sulfur dioxide)
CID 159191966
2-[4-(2-Morpholin-4-ylethoxy)anilino]-5,7-dihydropyrimido[5,4-d][1]benzazepin-6-one;2-[(6-morpholin-4-yl-3-pyridinyl)amino]-5,7-dihydropyrimido[5,4-d][1]benzazepin-6-one;2-[[1-(oxan-4-yl)pyrazol-4-yl]amino]-5,7-dihydropyrimido[5,4-d][1]benzazepin-6-one;2-(4-piperazin-1-ylanilino)-5,7-dihydropyrimido[5,4-d][1]benzazepin-6-one;2-[(6-piperazin-1-yl-3-pyridinyl)amino]-5,7-dihydropyrimido[5,4-d][1]benzazepin-6-one
CID 160063078
Bis(5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one);5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one
CID 160831190
6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide
CID 161065171
(2S)-2-(4-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-(3-methylpyrazol-1-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-(4-methylpyrazol-1-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-(4-methylpyrazol-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-(4-methylpyrazol-1-yl)-2-pyridinyl]-2-phenylacetamide
CID 161116039
(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;bis((2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide);bis((2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide);bis(sulfur dioxide)
CID 161458487
N,N-diethyl-1-[6-[[(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetyl]amino]-3-pyridinyl]piperidine-4-carboxamide;N,N-diethyl-1-[6-[[(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetyl]amino]-3-pyridinyl]piperidine-4-carboxamide;(2S)-2-(4-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-(4-methylpyrazol-1-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-(4-methylpyrazol-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-(4-methylpyrazol-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-(4-methylpyrazol-1-yl)-2-pyridinyl]-2-phenylacetamide
CID 167712123
(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide
CID 159191967

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide?
The IUPAC name of (2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide (CID 167664064) is (2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide.
What is the SMILES notation for (2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide?
The canonical SMILES for (2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide is CC(=O)N1CCN(c2ccc(NC(=O)[C@@H](NCCc3ccc(C)cc3)c3ccccc3)nc2)CC1.CC(=O)N1CCN(c2ccc(NC(=O)[C@H](NCCc3ccc(C)cc3)c3ccccc3)nc2)CC1.COc1cccc([C@@H](NCCc2ccc(C)cc2)C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c1.COc1cccc([C@H](NCCc2ccc(C)cc2)C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCC(=O)N(C)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCN(C)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCC(=O)N(C)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCN(C)CC3)cn2)c2ccccc2)cc1.
What is the InChIKey of (2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide?
The InChIKey is SJKTZVZYROLZTK-YLOBAREHSA-N. The full InChI is InChI=1S/4C28H33N5O2.2C27H29N5O2.2C27H33N5O/c2*1-21-8-10-22(11-9-21)14-16-29-27(23-6-4-3-5-7-23)28(35)31-25-13-12-24(20-30-25)33-17-15-26(34)32(2)18-19-33;2*1-21-8-10-23(11-9-21)14-15-29-27(24-6-4-3-5-7-24)28(35)31-26-13-12-25(20-30-26)33-18-16-32(17-19-33)22(2)34;2*1-19-7-9-20(10-8-19)13-14-28-26(21-5-4-6-24(15-21)34-3)27(33)31-25-12-11-22(16-29-25)23-17-30-32(2)18-23;2*1-21-8-10-22(11-9-21)14-15-28-26(23-6-4-3-5-7-23)27(33)30-25-13-12-24(20-29-25)32-18-16-31(2)17-19-32/h4*3-13,20,27,29H,14-19H2,1-2H3,(H,30,31,35);2*4-12,15-18,26,28H,13-14H2,1-3H3,(H,29,31,33);2*3-13,20,26,28H,14-19H2,1-2H3,(H,29,30,33)/t4*27-;4*26-/m10101010/s1.
What are the key properties of (2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide?
(2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide has a molecular weight of 3684.73 g/mol, XLogP of 30.21, 66 rotatable bonds, 16 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-methoxyphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2S)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4-methyl-5-oxo-1,4-diazepan-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]-2-phenylacetamide is sourced from PubChem (CID 167664064), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).